71. 72. Krotoski, W.A., Knudsen, K., Cogswell, F.B., and Conard, R.A. Efficacy of mebendazole against the helminth parasites of a Pacific Island population. Presented at 28th Annu. Meet. Am. Soc. Tropical Med. and Hyg., Tucson, AZ, Nov. 1979. Krotoski, W.A., Cogswell, F.B., Conard, R.A., and Pratt, H.S. Comparison between mebendazole and pyrantel pamoate against the helminth para- sites of two Pacific Island populations. 73. Presented at 15th Annu. Meet. USPHS Professional Assoc., Houston, TX, May 1980. Storch, G.A., Gunn, R.A., Martin, W.T., Pollard, R.A., and Sinclair, S.P. Shigellosis in the Marshall Islands: Epidemiologic aspects of an 74. outbreak. Am. J. Trop. Med. Hyg. 29: 456-63 (1980). West, K.M. Diabetes in American Indians and other native populations of 75. Zimmet, P. 76, 77. 78. 79. 80. 81. 82. the New World. Diabetes 23: 841 (1974). et al. The high prevalence of diabetes mellitus on a Central Pacific Island. Diabetologia 13: 111 (1977). Zimmet, P.Z. and Taft, P. The high prevalance of diabetes mellitus on a Central Pacific Island, in: Epidemiology of Diabetes, M. Miller and P.H. Bennett, Eds., Academic, New York, 1976. Zimmet, P.Z. et al. High prevalence of hyperuremia and gout in an urbanized Micronesian population. Br. Med. J. 1: 1237 (1978). Zimmet, P. and Whitehouse, S. The effect of age on glucose tolerance: Studies in a Micronesian population with a high prevalence of diabetes. Diabetes 28: 617 (1979). Prior, I1.A.M. et al. Hyperuricaemia, gout and diabetic abnormality in a Polynesian people. Lancet 1: 333 (1966). Prior, I.A.M. A health survey in a rural Maori community with particular emphasis on cardiovascular, nutritional, and metabolic findings. New Zealand Med. J. 61: 333 (1962). Brill, A.B., Tomonaga M., and Heyssel, R.M. Leukemia in man following exposure to ionizing radiation. sure, and type of leukemia. 83. 84. 85. 86. 87. Ann. Int. Med. 56: 590-609 (1962). Ichimaru, M., Ishimaru, T., and Belsky, J.L. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950-71: Radiation dose, years after exposure, age at expo10-76). Moloney, W.C. J. Radiat. Res. 19: 262-82 (1978) (RERF TR Leukemia and survivors of atomic bombing. Med. 253: 88-90 (1955). Parker, L., Belsky, J.L., Yamamoto, T., Kawamoto, S., New Eng. J. and Keehn, R.J. Thyroid carcinoma after exposure to atomic radiation. Ann. Int. Med. 80: 600-4 (1974). Manabe, Y., Toyoda, E., and Yamamoto, T. Thyroid carcinoma in atomicbomb survivors of Hiroshima and Nagasaki, 1958-1976. Hiroshima Igaku 31(4): 421-3 (1978). Hollingsworth, D.R., Hamilton, H.B., Tamagaki, H., and Beebe, G.W. Thy- roid disease: A study in Hiroshima, Japan. Medicine (Baltimore) 42: 47 (1963). Sampson, R.J., Key, C.R., Buncher, C.R., and Tijima, S. Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. JAMA 209: 65-70 (1969). - 93 -